Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 2 3Phase 4 2Phase 1 2Phase 3 1Phase 2/3 1

Status

Completed 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Breast 1

Conditions

Anemia 30Neoplasms 21Febrile Neutropenia 19Venous Thromboembolism 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Neutropenia 5Leukemia, Myeloid, Acute 5Colorectal Neoplasms 5Pulmonary Embolism 4Myelodysplastic Syndromes 4Leukemia 4Fever 4Anemia, Iron-Deficiency 4Venous Thrombosis 3Thrombocytopenia 3Ovarian Neoplasms 3Multiple Myeloma 3Lymphoma, Non-Hodgkin 3Hematologic Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Vitamin D Deficiency 2Uterine Cervical Neoplasms 2Stomach Neoplasms 2Sepsis 2Recurrence 2Postoperative Complications 2Lymphoma, Follicular 2Lymphoma 2Infections 2

Interventions

Epoetin Alfa 1Darbepoetin alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Fatigue × Classical hematology × Clear all
NCT00022386 2013-07-18

Epoetin Alfa in Treating Chemotherapy-Related Anemia in Women With Stage I, Stage II, or Stage III Breast Cancer

National Cancer Institute (NCI)

Phase 4 Completed
BreastClassical hematology

Anemia, Breast Neoplasms, Fatigue

NCT00117039 2008-10-15

A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia

Amgen

Phase 4 Completed
1,500 enrolled
Classical hematology

Anemia, Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡